legislation: 102-hr-6038
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102-hr-6038 | 102 | hr | 6038 | To amend title 35, United States Code, to permit separate patent extensions for each product under a patent which is subject to full regulatory review and approval. | Commerce | 1992-09-25 | 1992-09-28 | Referred to the Subcommittee on Intellectual Property and Judicial Administration. | House | Rep. Levine, Mel [D-CA-27] | CA | D | L000264 | 0 | Amends Federal patent law to permit separate patent extensions for certain drug products: (1) under a patent which is subject to full regulatory review and approval; and (2) which were developed at a qualified nonprofit institution of higher education. | 2025-01-16T12:12:20Z |